Farther Finance Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.12M | Buy |
103,138
+33,794
| +49% | +$2.33M | 0.14% | 133 |
|
|
2025
Q1 | $4.72M | Buy |
69,344
+19,061
| +38% | +$1.3M | 0.12% | 161 |
|
|
2024
Q4 | $4.33M | Buy |
50,283
+20,546
| +69% | +$1.77M | 0.16% | 117 |
|
|
2024
Q3 | $3.54M | Buy |
29,737
+3,137
| +12% | +$374K | 0.13% | 134 |
|
|
2024
Q2 | $3.87M | Sell |
26,600
-292
| -1% | -$42.5K | 0.19% | 91 |
|
|
2024
Q1 | $3.43M | Sell |
26,892
-7,030
| -21% | -$897K | 0.21% | 91 |
|
|
2023
Q4 | $3.51M | Buy |
33,922
+29,425
| +654% | +$3.04M | 0.25% | 79 |
|
|
2023
Q3 | $409K | Buy |
4,497
+4,435
| +7,153% | +$403K | 0.06% | 231 |
|
|
2023
Q2 | $5.02K | Sell |
62
-68
| -52% | -$5.5K | ﹤0.01% | 1433 |
|
|
2023
Q1 | $10.3K | Buy |
130
+92
| +242% | +$7.32K | ﹤0.01% | 1099 |
|
|
2022
Q4 | $2.57K | Buy |
+38
| New | +$2.57K | ﹤0.01% | 1368 |
|